PRTA - プロセナ (Prothena Corporation plc)

PRTAのニュース

   Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)  2020/12/04 21:05:00 GlobeNewswire
DUBLIN, Ireland, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein…
   U.S. Transthyretin Amyloidosis Treatment Market - Alnylam Pharmaceuticals, Inc., Pfizer, Inc., Prothena Corporation Plc, GlaxoSmithKline Plc, Ionis Pharmaceuticals, Inc., Eidos Therapeutics, and SOM Innovation Biotech, S.L.  2020/11/17 12:32:08 OpenPR
Industrial Growth Forecast Report U.S. Transthyretin Amyloidosis Treatment Market 2020-2027: The Global U.S. Transthyretin Amyloidosis Treatment Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global U.S. Transthyretin Amyloidosis Treatment Market business, including
   Prothena Reports Third Quarter 2020 Financial Results and Provides R&D Update  2020/11/04 21:05:00 GlobeNewswire
Net cash used in operating and investing activities was $19.5 million in the third quarter and $61.4 million for the first nine months of 2020; quarter-end…
   Prothena Announces Presentations on Two Programs from its Alzheimer’s Disease Portfolio at CTAD 2020  2020/11/04 13:30:00 GlobeNewswire
Next generation anti-Aβ antibodies being developed for subcutaneous administration to improve access for patients with Alzheimer’s diseaseMulti-immunogen…
   Prothena to Report Third Quarter 2020 Financial Results on November 4  2020/10/28 20:05:00 GlobeNewswire
DUBLIN, Ireland, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein…
   Prothena Reports Third Quarter 2020 Financial Results and Provides R&D Update  2020/11/04 21:05:00 GlobeNewswire
Net cash used in operating and investing activities was $19.5 million in the third quarter and $61.4 million for the first nine months of 2020; quarter-end…
   Prothena Announces Presentations on Two Programs from its Alzheimer’s Disease Portfolio at CTAD 2020  2020/11/04 13:30:00 GlobeNewswire
Next generation anti-Aβ antibodies being developed for subcutaneous administration to improve access for patients with Alzheimer’s diseaseMulti-immunogen…
   Prothena to Report Third Quarter 2020 Financial Results on November 4  2020/10/28 20:05:00 GlobeNewswire
DUBLIN, Ireland, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein…
   FY2020 EPS Estimates for Prothena Co. PLC (NASDAQ:PRTA) Reduced by Analyst  2020/10/25 01:38:47 Dispatch Tribunal
Prothena Co. PLC (NASDAQ:PRTA) – Equities researchers at Cantor Fitzgerald cut their FY2020 EPS estimates for Prothena in a report released on Wednesday, October 21st. Cantor Fitzgerald analyst C. Duncan now anticipates that the biotechnology company will post earnings of ($2.59) per share for the year, down from their prior estimate of ($2.54). Cantor Fitzgerald […]
   Prothena Co. PLC (NASDAQ:PRTA) Expected to Post Earnings of -$0.68 Per Share  2020/10/24 11:40:48 Transcript Daily
Equities research analysts expect Prothena Co. PLC (NASDAQ:PRTA) to report earnings per share of ($0.68) for the current quarter, Zacks reports. Three analysts have made estimates for Prothena’s earnings, with the highest EPS estimate coming in at ($0.66) and the lowest estimate coming in at ($0.70). Prothena posted earnings of ($0.49) per share during the […]
   Prothena to Report Third Quarter 2020 Financial Results on November 4  2020/10/28 20:05:00 GlobeNewswire
DUBLIN, Ireland, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein…
   FY2020 EPS Estimates for Prothena Co. PLC (NASDAQ:PRTA) Reduced by Analyst  2020/10/25 01:38:47 Dispatch Tribunal
Prothena Co. PLC (NASDAQ:PRTA) – Equities researchers at Cantor Fitzgerald cut their FY2020 EPS estimates for Prothena in a report released on Wednesday, October 21st. Cantor Fitzgerald analyst C. Duncan now anticipates that the biotechnology company will post earnings of ($2.59) per share for the year, down from their prior estimate of ($2.54). Cantor Fitzgerald […]
   Prothena Co. PLC (NASDAQ:PRTA) Expected to Post Earnings of -$0.68 Per Share  2020/10/24 11:40:48 Transcript Daily
Equities research analysts expect Prothena Co. PLC (NASDAQ:PRTA) to report earnings per share of ($0.68) for the current quarter, Zacks reports. Three analysts have made estimates for Prothena’s earnings, with the highest EPS estimate coming in at ($0.66) and the lowest estimate coming in at ($0.70). Prothena posted earnings of ($0.49) per share during the […]
   Prothena (NASDAQ:PRTA) Shares Gap Up on Analyst Upgrade  2020/10/23 05:38:41 Dakota Financial News
Prothena Co. PLC (NASDAQ:PRTA) gapped up prior to trading on Wednesday after Cantor Fitzgerald raised their price target on the stock from $20.00 to $24.00. The stock had previously closed at $11.26, but opened at $12.61. Cantor Fitzgerald currently has an overweight rating on the stock. Prothena shares last traded at $12.10, with a volume […]
   Prothena (NASDAQ:PRTA) Shares Gap Up Following Analyst Upgrade  2020/10/21 22:26:44 Daily Political
Prothena Co. PLC (NASDAQ:PRTA) shares gapped up prior to trading on Wednesday after Cantor Fitzgerald raised their price target on the stock from $20.00 to $24.00. The stock had previously closed at $11.26, but opened at $12.61. Cantor Fitzgerald currently has an overweight rating on the stock. Prothena shares last traded at $12.10, with a […]

calendar